Clinical Trial Detail

NCT ID NCT04166383
Title VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

colorectal cancer

Therapies

Nivolumab + VB-111

Age Groups: adult senior

No variant requirements are available.